Deferasirox
- Product NDC
- 67877-550
- 11-digit product format
- 678770550
- Labeler code
- 67877
- Product ID
- 67877-550_1a5b6d3f-ad5c-43f7-bed3-4b51ae26f872
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA210519
- Marketing category
- ANDA
- Marketing start
- 2019-11-22
- Substance
- DEFERASIROX
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Deferasirox
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFERASIROX | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V8G4MOF2V9 |
| Rxcui | 597768, 597770, 597772 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67877-550-30 | Deferasirox | 30 in 1 BOTTLE | TABLET, FOR SUSPENSION | 30 | | 17 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67877-550 | DEFERASIROX TABLET, FOR SUSPENSION [ASCEND LABORATORIES, LLC] | 15 | Current NDC, Legacy NDC, 1 package rows | 20220528_da3295fc-5210-46a3-a5cc-7b9ec9265eca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67877-550-30 | 67877055030 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (67877-550-30) | 2019-11-22 | 0000-00-00 | No | No | Current |